NPPA orders pharmaceutical companies to lower drug prices post-GST reduction, effective 22, 2025. Compliance measures ...

The government has mandated pharma companies to revise the Maximum Retail Price (MRP) of medicines, formulations, and medical ...

Centre permits revised MRPs on unsold stock after GST changes till 31 Dec 2025, subject to conditions on stamping, display, and consumer ...

The Department of Consumer Affairs has asked the industry—manufacturers, packers and importers—to place at least two ...

The GST Council has revised rates of a range of fast-moving consumer goods (FMCG), effective from September 22, reducing them ...

Separately, the finance ministry is studying mechanisms to help businesses deal with potential losses from new inverted duty ...

The government has allowed companies that released stock before September 22 to neither recall it nor put new labels on it.

Jharkhand DC issues guidelines on MRP revisions of medicines post-GST amendments: Peethaambaran Kunnathoor, Chennai Thursday, September 11, 2025, 08:00 Hrs [IST] In response to th ...

The Centre has allowed FMCG firms to revise MRPs on unsold stocks until Dec 31, 2025, easing concerns over GST 2.0 rate ...

NPPA directs pharma, medical devices industries to implement GST cut: Our Bureau, New Delhi Saturday, September 13, 2025, 13:40 Hrs [IST] The National Pharmaceutical Pricing Autho ...

Through a circular, the Ministry of Consumer Affairs has extended this facility to manufacturers, packers and importers of pre-packaged goods for unsold stock or inventory with them till September 22, ...

The Department of Consumer Affairs has allowed manufacturers, packers and importers to revise MRP on unsold stock using ...